Myopathic alterations in extraocular muscle of rats subchronically fed pyridostigmine bromide.
To determine if alterations in extraocular muscle morphology occur after subchronic oral administration of pyridostigmine bromide, rats were continuously fed 90 mg/kg in meal and examined at 1, 2, 4, 7, and 15 days. Within the first day, blood acetylcholinesterase activity was reduced by 87% and remained inhibited by 74-91% during the study. Light microscopy demonstrated that by day 1 approximately 3% of the extraocular myofibers were shrunken and invaded by inflammatory cells. The most severe degenerative changes consisting of vacuoles and inflammatory cell infiltration occurred at day 1 with progressively less severe changes at days 2 and 4. At days 7 and 15, 1.3-4.5% of the myofibers still exhibited damage. Ultrastructurally, all presynaptic areas were normal but the postsynaptic areas of affected myofibers at days 1, 2, and 4 showed myofilament and Z-band dissolution, mitochondrial inclusions, subneural fold and T-tubule/sarcoplasmic reticulum vacuolization and subneural fold depth reduction. By days 7 and 15, these changes were diminished in some cases and in others alterations appeared similar to day 1. We conclude that subchronic feeding of pyridostigmine bromide induces myopathic rather than neurogenic changes in rat extraocular muscle and that the myopathy is different in these muscles than in the diaphragm from the the same rats.
Schuschereba
S T
ST
Letterman Army Institute of Research, Presidio of San Francisco, California 94129-6800.
Bowman
P D
PD
Vargas
J A
JA
Johnson
T W
TW
Woo
F J
FJ
McKinney
L
L
D000818:Animals; D002118:Calcium / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000187:drug effects* / Q000473:pathology / Q000648:ultrastructure; D009469:Neuromuscular Junction / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D011729:Pyridostigmine Bromide / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains
D011729:Pyridostigmine Bromide; D002118:Calcium